Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts

BJU International

Volumn 98, Issue 3, 2006, Pages 656-660

  Umekawa, Tohru ^a   Iguchi, Masanori ^a   Uemura, Hirotsugu ^a   Khan, Saeed R ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Calcium oxalate; Fibroblasts; Inflammation; Kidney stones; MCP 1; Osteopontin

Indexed keywords

CALCIUM OXALATE; LACTATE DEHYDROGENASE; LIPID; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; OXALIC ACID; REACTIVE OXYGEN METABOLITE; TRYPAN BLUE;

ANIMAL CELL; ARTICLE; CALCIUM OXALATE STONE; FIBROBLAST; HYPEROXALURIA; IN VITRO STUDY; INTERSTITIAL NEPHRITIS; KIDNEY EPITHELIUM; KIDNEY INTERSTITIUM; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; CALCIUM OXALATE; CELLS, CULTURED; CHEMOKINE CCL2; CRYSTALLIZATION; FIBROBLASTS; IONS; KIDNEY; OSTEOPONTIN; OXALATES; RATS; SIALOGLYCOPROTEINS; UP-REGULATION;

EID: 33746878806     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06334.x     Document Type: Article

References (29)

1. Khan SR. Calcium oxalate crystal interaction with renal epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 1995; 23: 71-9
2. Lieske JC, Spargo BH, Toback FG. Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 1992; 148: 1517-9
3. De Water R, Noordermeer C, van der Kwast TH et al. Calcium oxalate nephrolithiasis in rats: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 1999; 33: 761-71
4. Lieske JC, Hammes MS, Hoyer JR, Toback FG. Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals. Kidney Intl 1997; 51: 679-86
5. Umekawa T, Chegini N, Khan SR. Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Intl 2002; 61: 105-12
6. Toblli JE, Ferder L, Stella I, De Cavanaugh EM, Angerosa M, Inserra F. Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 2002; 168: 1550-5
7. Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F. Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 2001; 166: 275-80
8. Khan SR, Kok DJ. Modulators of urinary stone formation. Front Biosci 2004; 9: 1450-82
9. Khan SR, Johnson JM, Peck AB, Cornelius JM, Glenton PA. Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 2002; 168: 1173-81
10. Wesson JA, Johnson RJ, Mazzali M et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 2003; 14: 139-47
11. Antus B, Exton MS, Rosivall L. Angiotensin II: a regulator of inflammation during renal disease? Int J Immunopathol Pharmacol 2001; 14: 25-30
12. Umekawa T, Hatanaka Y, Kurita T, Khan SR. Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in the rat kidneys. J Am Soc Nephrol 2004; 15: 635-44
13. Hautmann R, Osswald H. Concentration profiles of calcium and oxalate in urine, tubular fluid and renal tissue - some theoretical considerations. J Urol 1983; 129: 433-6
14. Knoll T, Steidler A, Trojan L et al. The influence of oxalate on renal epithelial and interstitial cells. Urol Res 2004; 32: 304-9
15. Cao Z, Cooper ME. Role of angiotensin II in tubulointerstitial injury. Semin Nephrol 2001; 21: 554-62
16. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998; 152: 353-8
17. Giachelli CM, Pichler R, Lombardi D et al. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994; 45: 515-24
18. Ricardo SD, Franzoni DF, Roesener CD, Crisman JM, Diamond JR. Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells. Am J Physiol Renal Physiol 2000; 278: F708-16
19. Rashed T, Menon M, Thamilselvan S. Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 2004; 24: 557-68
20. Jonassen JA, Cao LC, Honeyman T, Scheid CR. Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 2003; 13: 55-72
21. Maroni PD, Koul S, Chandhoke PS, Meacham RB, Koul HK. Oxalate toxicity in cultured mouse inner medullary collecting duct cells. J Urol 2005; 174: 757-60
22. Knight JA. Free radicals: their history and current status in aging and disease. Ann Clin Lab Sci 1998; 28: 331-46
23. Jaimes EA, Galceran JM, Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 1998; 54: 775-84
24. Hannken T, Schroeder R, Stahl RA, Wolf G. Angiotensin II mediated expression of p27Kip 1 and induction of cellular hypertrophy in renal tubular cells depend on generation of oxygen radicals. Kidney Int 1998; 54: 1923-33
25. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schiondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G. Evidence for the involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 1993; 92: 1564-71
26. 2, and iron are required for TNF-α-induced MCP-1 gene expression in endothelial cells: role of Rac 1 and NADPH oxidase. Am J Physiol Heart Circ Physiol 2004; 286: H1001-7
27. Baykal Y, Yilmaz MI, Celik T et al. Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress. J Hypertens 2003; 21: 1207-11
28. Agarwal R. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Am J Physiol Renal Physiol 2003; 284: F863-9
29. Umekawa T, Byer K, Uemura H, Khan SR. Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant 2005; 20: 870-8